MājasSport

Sport

Chelsea’s defence looks ‘weak & disjointed’

Redakcija - September 13, 2026

Sport

Referee ‘completely wrong’ to award penalty

Sport

‘Today the game was unprotected’

Sport

Arsenal hold off energetic Sunderland to continue perfect title defence

Sport

Arteta ‘very worried & very sad’ over penalty incident

Sport

Barcelona’s sleek 2025/26 home kit drops ahead of Camp Nou return

Redakcija - July 4, 2025

Sport

AC Milan revive iconic devil emblem for incredible 2025/26 away kit

Redakcija - July 4, 2025

Sport

England Under-21s celebrate European Championship success in style

Redakcija - July 3, 2025

Sport

Newcastle pay tribute to club’s history with swish 2025/26 third kit

Redakcija - July 3, 2025

Sport

Liga MX reveals bold 2025 All-Star kit featuring mascots and club icons

Redakcija - July 3, 2025

Sport

Lionel Messi shown ultimate respect by PSG’s players after Club World Cup clash

Redakcija - July 3, 2025

Sport

Myles Lewis-Skelly hits Paris Fashion Week runway, caps incredible Arsenal week

Redakcija - July 3, 2025

Sport

Reece James shares what Chelsea did during two-hour thunderstorm delay

Redakcija - July 2, 2025

Sport

AS Monaco reveal first-ever Mizuno home kit with assist from Paul Pogba

Redakcija - July 2, 2025

Sport

Wolves unveil 2025/26 home kit featuring unique twist

Redakcija - June 30, 2025

Sport

Podcast: Hearts disrupting duopoly & Dundee captain Murray

Redakcija - June 30, 2025

Sport

adidas celebrates power of competition in new UEFA Women’s EURO 2025 film

Redakcija - June 29, 2025

1...133134135 136 No 136 134 lapa

Sport

Chelsea’s defence looks ‘weak & disjointed’

Referee ‘completely wrong’ to award penalty

‘Today the game was unprotected’

Arsenal hold off energetic Sunderland to continue perfect title defence

Arteta ‘very worried & very sad’ over penalty incident

الأكثر قراءة

Training nurses like athletes

Trial supports MRI surveillance over preventive brain radiation in small-cell lung cancer

Combination therapy does not meet primary endpoints in first-line PD-L1-high metastatic non-small cell lung cancer

Trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer